CRV designed the microarray study, participated in microarray hybridizations, data extraction and analysis, coordination, and wrote the manuscript.
LB: performed statistical and bioinformatic analysis of microarray data; IB-N: carried out the RT-PCR study; OB: carried out the microarray study; participated in the study's design and drafted the manuscript.
W-MG carried out the antibody microarray studies, participated in the statistical treatment of the data and drafted the manuscript.
Author 1 (BST) carried out the phenotype microarray studies, participated in the confirmation tests, compiled data for and edited the manuscript.
AJK, initiated and contributed to the design of the oligonucleotides used for the microarray, setup, designed and carried out (part of) the microarray studies, participated in the MLST-, MLVA -and microarray data analysis and wrote the manuscript.
CS was responsible for the design of the study, participated in the microarray experiments, analysed the microarray data and drafted the manuscript.
CJC conceived the study, participated in microarray data analyses and drafted the manuscript.
CJC conceived the study, participated in microarray data analyses and in BAN generation.
RK designed the study, participated in microarray analyses, statistical analyses, drafted the manuscript, read and approved the final version of the manuscript.
YW conceived and designed the study, participated in the microarray data collection, performed data analysis and wrote the article.
AW designed the study, participated in tissue microarray construction, immunohistochemical analyses, drafted the manuscript, read and approved the final version of the manuscript.
